Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 91227 | HLA-DR (HLA-DR) | thromboangiitis obliterans | NA | NA | NA | unclassified | |
| the incidence of thromboangiitis obliterans in brothers and the high prevalence in some ethnic groups have led us to investigate the histocompatibility hla-a, b and dr antigens of 46 buerger's disease patients. | |||||||
| 91227 | HLA LINKED (HLA-LINKED) | buergers disease | NA | NA | NA | positive | |
| evidence for an hla-linked resistance gene in buerger's disease. | |||||||
| 91227 | HLA (HLA) | buergers disease | NA | NA | NA | negation | |
| our study suggests that buerger's disease is, on the basis of hla antigens, a distinct immunogenetic entity and not a particular form of arteriosclerosis. | |||||||
| 91227 | HLA (HLA) | arteriosclerosis | NA | NA | NA | negation | |
| our study suggests that buerger's disease is, on the basis of hla antigens, a distinct immunogenetic entity and not a particular form of arteriosclerosis. | |||||||
| 1802501 | HLA (HLA) | thromboangiitis obliterans | Greek | NA | NA | only_studied | |
| the hla a and b types of 20 greek patients with thromboangiitis obliterans (tao) were studied and compared with a panel of 400 controls. | |||||||
| 8412397 | HLA (HLA) | thromboangiitis obliterans | NA | NA | NA | unclassified | |
| there is a significant increase of determined hla antigens and anticollagen antibodies in the patients with thromboangiitis obliterans. | |||||||
| 16611256 | HLA (HLA) | arteriosclerosis obliterans | NA | NA | NA | only_studied | |
| we examined the genetic status of human leucocyte antigens (hla), human platelet alloantigens (hpa) and neutrophil-specific antigens (na) in patients with type 2 diabetes mellitus and diabetic arteriosclerosis obliterans (aso). | |||||||
| 16611256 | HLA (HLA) | type 2 diabetes mellitus | NA | NA | NA | only_studied | |
| we examined the genetic status of human leucocyte antigens (hla), human platelet alloantigens (hpa) and neutrophil-specific antigens (na) in patients with type 2 diabetes mellitus and diabetic arteriosclerosis obliterans (aso). | |||||||
| 16611256 | HLA (HLA) | type 2 diabetes | NA | NA | NA | unclassified | |
| genetic analysis of hla, na and hpa typing in type 2 diabetes and aso. | |||||||
| 16611256 | HLA-DRB1*15 | type 2 diabetes | NA | NA | NA | positive | |
| the incidence of hla-drb1*1501 was found to be significant in type 2 diabetes and non-diabetic, particularly aso-positive patients, compared to control subjects. | |||||||
Copyright 2024